CVE-2025-2230 (GCVE-0-2025-2230)
Vulnerability from cvelistv5 – Published: 2025-03-13 18:14 – Updated: 2025-03-17 20:05
VLAI
EPSS
VEX
Title
Philips Intellispace Cardiovascular (ISCV) Improper Authentication
Summary
A flaw exists in the Windows login flow where an AuthContext token can
be exploited for replay attacks and authentication bypass.
Severity
SSVC
Exploitation: none
Automatable: no
Technical Impact: total
CISA Coordinator · CISA-ADP (v2.0.3)
Decision recorded 2025-03-13 19:33 UTC
CWE
- CWE-287 - Improper Authentication
Assigner
References
Impacted products
1 product
| Vendor | Product | Version | CPE status | |
|---|---|---|---|---|
| Philips | Intellispace Cardiovascular (ISCV) |
Affected:
0 , ≤ 5.1
(custom)
|
guessed |
{
"containers": {
"adp": [
{
"metrics": [
{
"other": {
"content": {
"id": "CVE-2025-2230",
"options": [
{
"Exploitation": "none"
},
{
"Automatable": "no"
},
{
"Technical Impact": "total"
}
],
"role": "CISA Coordinator",
"timestamp": "2025-03-13T19:33:45.514056Z",
"version": "2.0.3"
},
"type": "ssvc"
}
}
],
"providerMetadata": {
"dateUpdated": "2025-03-13T19:34:02.967Z",
"orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
"shortName": "CISA-ADP"
},
"title": "CISA ADP Vulnrichment"
}
],
"cna": {
"affected": [
{
"defaultStatus": "unaffected",
"product": "Intellispace Cardiovascular (ISCV)",
"vendor": "Philips",
"versions": [
{
"lessThanOrEqual": "5.1",
"status": "affected",
"version": "0",
"versionType": "custom"
}
]
}
],
"credits": [
{
"lang": "en",
"type": "finder",
"value": "Joe Dillon reported these vulnerabilities to Philips."
}
],
"descriptions": [
{
"lang": "en",
"supportingMedia": [
{
"base64": false,
"type": "text/html",
"value": "A flaw exists in the Windows login flow where an AuthContext token can \nbe exploited for replay attacks and authentication bypass."
}
],
"value": "A flaw exists in the Windows login flow where an AuthContext token can \nbe exploited for replay attacks and authentication bypass."
}
],
"metrics": [
{
"cvssV3_1": {
"attackComplexity": "LOW",
"attackVector": "LOCAL",
"availabilityImpact": "NONE",
"baseScore": 7.7,
"baseSeverity": "HIGH",
"confidentialityImpact": "HIGH",
"integrityImpact": "HIGH",
"privilegesRequired": "NONE",
"scope": "UNCHANGED",
"userInteraction": "NONE",
"vectorString": "CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N",
"version": "3.1"
},
"format": "CVSS",
"scenarios": [
{
"lang": "en",
"value": "GENERAL"
}
]
},
{
"cvssV4_0": {
"Automatable": "NOT_DEFINED",
"Recovery": "NOT_DEFINED",
"Safety": "NOT_DEFINED",
"attackComplexity": "LOW",
"attackRequirements": "NONE",
"attackVector": "LOCAL",
"baseScore": 8.5,
"baseSeverity": "HIGH",
"privilegesRequired": "NONE",
"providerUrgency": "NOT_DEFINED",
"subAvailabilityImpact": "NONE",
"subConfidentialityImpact": "NONE",
"subIntegrityImpact": "NONE",
"userInteraction": "NONE",
"valueDensity": "NOT_DEFINED",
"vectorString": "CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N",
"version": "4.0",
"vulnAvailabilityImpact": "NONE",
"vulnConfidentialityImpact": "HIGH",
"vulnIntegrityImpact": "HIGH",
"vulnerabilityResponseEffort": "NOT_DEFINED"
},
"format": "CVSS",
"scenarios": [
{
"lang": "en",
"value": "GENERAL"
}
]
}
],
"problemTypes": [
{
"descriptions": [
{
"cweId": "CWE-287",
"description": "CWE-287 Improper Authentication",
"lang": "en",
"type": "CWE"
}
]
}
],
"providerMetadata": {
"dateUpdated": "2025-03-17T20:05:56.939Z",
"orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
"shortName": "icscert"
},
"references": [
{
"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-072-01"
},
{
"url": "https://www.philips.com/a-w/security/security-advisories.html"
}
],
"solutions": [
{
"lang": "en",
"supportingMedia": [
{
"base64": false,
"type": "text/html",
"value": "\u003cp\u003ePhilips recommends the following mitigations:\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\n\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003eResolved in ISCV 5.2, which was released in September 2020.\u003c/span\u003e\n\n\u003c/li\u003e\n\n\u003cli\u003ePhilips recommends users upgrade ISCV installed base to the latest \nISCV version (at the time of this publication is 830089 \u2013 IntelliSpace \nCardiovacular 8.0.0.0)\u003c/li\u003e\n\u003cli\u003ePlease contact a local Philips sales (service) representative to learn how to engage this upgrade process.\u003c/li\u003e\n\u003cli\u003eFor managed services users, new releases will be made available upon\n resource availability. Releases are subject to country-specific \nregulations.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003eRefer to the \u003ca target=\"_blank\" rel=\"nofollow\" href=\"https://www.philips.com/a-w/security/security-advisories.html\"\u003ePhilips advisory\u003c/a\u003efor more details.\n\n\u003cbr\u003e\u003c/p\u003e"
}
],
"value": "Philips recommends the following mitigations:\n\n\n\n * \n\nResolved in ISCV 5.2, which was released in September 2020.\n\n\n\n\n * Philips recommends users upgrade ISCV installed base to the latest \nISCV version (at the time of this publication is 830089 \u2013 IntelliSpace \nCardiovacular 8.0.0.0)\n\n * Please contact a local Philips sales (service) representative to learn how to engage this upgrade process.\n\n * For managed services users, new releases will be made available upon\n resource availability. Releases are subject to country-specific \nregulations.\n\n\n\n\nRefer to the Philips advisory https://www.philips.com/a-w/security/security-advisories.html for more details."
}
],
"source": {
"advisory": "ICSMA-25-072-01",
"discovery": "EXTERNAL"
},
"title": "Philips Intellispace Cardiovascular (ISCV) Improper Authentication",
"x_generator": {
"engine": "Vulnogram 0.2.0"
}
}
},
"cveMetadata": {
"assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
"assignerShortName": "icscert",
"cveId": "CVE-2025-2230",
"datePublished": "2025-03-13T18:14:43.573Z",
"dateReserved": "2025-03-11T20:14:50.017Z",
"dateUpdated": "2025-03-17T20:05:56.939Z",
"state": "PUBLISHED"
},
"dataType": "CVE_RECORD",
"dataVersion": "5.1",
"vulnerability-lookup:meta": {
"epss": {
"cve": "CVE-2025-2230",
"date": "2026-10-30",
"epss": "0.00236",
"percentile": "0.14704"
},
"nvd": {
"cve": {
"affected": [
{
"affectedData": [
{
"defaultStatus": "unaffected",
"product": "Intellispace Cardiovascular (ISCV)",
"vendor": "Philips",
"versions": [
{
"lessThanOrEqual": "5.1",
"status": "affected",
"version": "0",
"versionType": "custom"
}
]
}
],
"source": "ics-cert@hq.dhs.gov"
}
],
"cveTags": [],
"descriptions": [
{
"lang": "en",
"value": "A flaw exists in the Windows login flow where an AuthContext token can \nbe exploited for replay attacks and authentication bypass."
},
{
"lang": "es",
"value": "Existe una falla en el flujo de inicio de sesi\u00f3n de Windows donde un token AuthContext puede ser explotado para ataques de repetici\u00f3n y evasi\u00f3n de autenticaci\u00f3n."
}
],
"id": "CVE-2025-2230",
"lastModified": "2026-06-17T09:06:35.333",
"metrics": {
"cvssMetricV31": [
{
"cvssData": {
"attackComplexity": "LOW",
"attackVector": "LOCAL",
"availabilityImpact": "NONE",
"baseScore": 7.7,
"baseSeverity": "HIGH",
"confidentialityImpact": "HIGH",
"integrityImpact": "HIGH",
"privilegesRequired": "NONE",
"scope": "UNCHANGED",
"userInteraction": "NONE",
"vectorString": "CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N",
"version": "3.1"
},
"exploitabilityScore": 2.5,
"impactScore": 5.2,
"source": "ics-cert@hq.dhs.gov",
"type": "Secondary"
}
],
"cvssMetricV40": [
{
"cvssData": {
"Automatable": "NOT_DEFINED",
"Recovery": "NOT_DEFINED",
"Safety": "NOT_DEFINED",
"attackComplexity": "LOW",
"attackRequirements": "NONE",
"attackVector": "LOCAL",
"availabilityRequirement": "NOT_DEFINED",
"baseScore": 8.5,
"baseSeverity": "HIGH",
"confidentialityRequirement": "NOT_DEFINED",
"exploitMaturity": "NOT_DEFINED",
"integrityRequirement": "NOT_DEFINED",
"modifiedAttackComplexity": "NOT_DEFINED",
"modifiedAttackRequirements": "NOT_DEFINED",
"modifiedAttackVector": "NOT_DEFINED",
"modifiedPrivilegesRequired": "NOT_DEFINED",
"modifiedSubAvailabilityImpact": "NOT_DEFINED",
"modifiedSubConfidentialityImpact": "NOT_DEFINED",
"modifiedSubIntegrityImpact": "NOT_DEFINED",
"modifiedUserInteraction": "NOT_DEFINED",
"modifiedVulnAvailabilityImpact": "NOT_DEFINED",
"modifiedVulnConfidentialityImpact": "NOT_DEFINED",
"modifiedVulnIntegrityImpact": "NOT_DEFINED",
"privilegesRequired": "NONE",
"providerUrgency": "NOT_DEFINED",
"subAvailabilityImpact": "NONE",
"subConfidentialityImpact": "NONE",
"subIntegrityImpact": "NONE",
"userInteraction": "NONE",
"valueDensity": "NOT_DEFINED",
"vectorString": "CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X",
"version": "4.0",
"vulnAvailabilityImpact": "NONE",
"vulnConfidentialityImpact": "HIGH",
"vulnIntegrityImpact": "HIGH",
"vulnerabilityResponseEffort": "NOT_DEFINED"
},
"source": "ics-cert@hq.dhs.gov",
"type": "Secondary"
}
],
"ssvcV203": [
{
"source": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
"ssvcData": {
"id": "CVE-2025-2230",
"options": [
{
"exploitation": "none"
},
{
"automatable": "no"
},
{
"technicalImpact": "total"
}
],
"role": "CISA Coordinator",
"timestamp": "2025-03-13T19:33:45.514056Z",
"version": "2.0.3"
}
}
]
},
"published": "2025-03-13T19:15:52.750",
"references": [
{
"source": "ics-cert@hq.dhs.gov",
"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-072-01"
},
{
"source": "ics-cert@hq.dhs.gov",
"url": "https://www.philips.com/a-w/security/security-advisories.html"
}
],
"sourceIdentifier": "ics-cert@hq.dhs.gov",
"vulnStatus": "Deferred",
"weaknesses": [
{
"description": [
{
"lang": "en",
"value": "CWE-287"
}
],
"source": "ics-cert@hq.dhs.gov",
"type": "Secondary"
}
]
}
},
"redhat_vex": {
"current_release_date": "2025-05-28T16:57:08+00:00",
"cve": "CVE-2025-2230",
"id": "CVE-2025-2230",
"initial_release_date": "2025-01-01T00:00:00+00:00",
"product_status:known_not_affected": "1",
"source": "Red Hat CSAF VEX",
"status": "final",
"title": "Philips Intellispace Cardiovascular (ISCV) Improper Authentication",
"url": "https://security.access.redhat.com/data/csaf/v2/vex/2025/cve-2025-2230.json",
"version": "3"
},
"vulnrichment": {
"containers": {
"adp": [
{
"metrics": [
{
"other": {
"content": {
"id": "CVE-2025-2230",
"options": [
{
"Exploitation": "none"
},
{
"Automatable": "no"
},
{
"Technical Impact": "total"
}
],
"role": "CISA Coordinator",
"timestamp": "2025-03-13T19:33:45.514056Z",
"version": "2.0.3"
},
"type": "ssvc"
}
}
],
"providerMetadata": {
"dateUpdated": "2025-03-13T19:33:56.303Z",
"orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
"shortName": "CISA-ADP"
},
"title": "CISA ADP Vulnrichment"
}
],
"cna": {
"affected": [
{
"defaultStatus": "unaffected",
"product": "Intellispace Cardiovascular (ISCV)",
"vendor": "Philips",
"versions": [
{
"lessThanOrEqual": "5.1",
"status": "affected",
"version": "0",
"versionType": "custom"
}
]
}
],
"credits": [
{
"lang": "en",
"type": "finder",
"value": "Joe Dillon reported these vulnerabilities to Philips."
}
],
"descriptions": [
{
"lang": "en",
"supportingMedia": [
{
"base64": false,
"type": "text/html",
"value": "A flaw exists in the Windows login flow where an AuthContext token can \nbe exploited for replay attacks and authentication bypass."
}
],
"value": "A flaw exists in the Windows login flow where an AuthContext token can \nbe exploited for replay attacks and authentication bypass."
}
],
"metrics": [
{
"cvssV3_1": {
"attackComplexity": "LOW",
"attackVector": "LOCAL",
"availabilityImpact": "NONE",
"baseScore": 7.7,
"baseSeverity": "HIGH",
"confidentialityImpact": "HIGH",
"integrityImpact": "HIGH",
"privilegesRequired": "NONE",
"scope": "UNCHANGED",
"userInteraction": "NONE",
"vectorString": "CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N",
"version": "3.1"
},
"format": "CVSS",
"scenarios": [
{
"lang": "en",
"value": "GENERAL"
}
]
},
{
"cvssV4_0": {
"Automatable": "NOT_DEFINED",
"Recovery": "NOT_DEFINED",
"Safety": "NOT_DEFINED",
"attackComplexity": "LOW",
"attackRequirements": "NONE",
"attackVector": "LOCAL",
"baseScore": 8.5,
"baseSeverity": "HIGH",
"privilegesRequired": "NONE",
"providerUrgency": "NOT_DEFINED",
"subAvailabilityImpact": "NONE",
"subConfidentialityImpact": "NONE",
"subIntegrityImpact": "NONE",
"userInteraction": "NONE",
"valueDensity": "NOT_DEFINED",
"vectorString": "CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N",
"version": "4.0",
"vulnAvailabilityImpact": "NONE",
"vulnConfidentialityImpact": "HIGH",
"vulnIntegrityImpact": "HIGH",
"vulnerabilityResponseEffort": "NOT_DEFINED"
},
"format": "CVSS",
"scenarios": [
{
"lang": "en",
"value": "GENERAL"
}
]
}
],
"problemTypes": [
{
"descriptions": [
{
"cweId": "CWE-287",
"description": "CWE-287 Improper Authentication",
"lang": "en",
"type": "CWE"
}
]
}
],
"providerMetadata": {
"dateUpdated": "2025-03-17T20:05:56.939Z",
"orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
"shortName": "icscert"
},
"references": [
{
"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-072-01"
},
{
"url": "https://www.philips.com/a-w/security/security-advisories.html"
}
],
"solutions": [
{
"lang": "en",
"supportingMedia": [
{
"base64": false,
"type": "text/html",
"value": "\u003cp\u003ePhilips recommends the following mitigations:\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\n\u003cspan style=\"background-color: rgb(255, 255, 255);\"\u003eResolved in ISCV 5.2, which was released in September 2020.\u003c/span\u003e\n\n\u003c/li\u003e\n\n\u003cli\u003ePhilips recommends users upgrade ISCV installed base to the latest \nISCV version (at the time of this publication is 830089 \u2013 IntelliSpace \nCardiovacular 8.0.0.0)\u003c/li\u003e\n\u003cli\u003ePlease contact a local Philips sales (service) representative to learn how to engage this upgrade process.\u003c/li\u003e\n\u003cli\u003eFor managed services users, new releases will be made available upon\n resource availability. Releases are subject to country-specific \nregulations.\u003c/li\u003e\n\u003c/ul\u003e\n\u003cp\u003eRefer to the \u003ca target=\"_blank\" rel=\"nofollow\" href=\"https://www.philips.com/a-w/security/security-advisories.html\"\u003ePhilips advisory\u003c/a\u003efor more details.\n\n\u003cbr\u003e\u003c/p\u003e"
}
],
"value": "Philips recommends the following mitigations:\n\n\n\n * \n\nResolved in ISCV 5.2, which was released in September 2020.\n\n\n\n\n * Philips recommends users upgrade ISCV installed base to the latest \nISCV version (at the time of this publication is 830089 \u2013 IntelliSpace \nCardiovacular 8.0.0.0)\n\n * Please contact a local Philips sales (service) representative to learn how to engage this upgrade process.\n\n * For managed services users, new releases will be made available upon\n resource availability. Releases are subject to country-specific \nregulations.\n\n\n\n\nRefer to the Philips advisory https://www.philips.com/a-w/security/security-advisories.html for more details."
}
],
"source": {
"advisory": "ICSMA-25-072-01",
"discovery": "EXTERNAL"
},
"title": "Philips Intellispace Cardiovascular (ISCV) Improper Authentication",
"x_generator": {
"engine": "Vulnogram 0.2.0"
}
}
},
"cveMetadata": {
"assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
"assignerShortName": "icscert",
"cveId": "CVE-2025-2230",
"datePublished": "2025-03-13T18:14:43.573Z",
"dateReserved": "2025-03-11T20:14:50.017Z",
"dateUpdated": "2025-03-17T20:05:56.939Z",
"state": "PUBLISHED"
},
"dataType": "CVE_RECORD",
"dataVersion": "5.1"
}
}
}
Loading…
Loading…
Drag nodes to arrange them. Double-click a related vulnerability to open it, or a source to visit its link. The Physics button on the left tunes the layout and the simulation; the legend at the bottom left hides or shows nodes by kind and by sighting type.
Experimental. This forecast is provided for visualization only and may change without notice. Do not use it for operational decisions.
Forecast uses a logistic model when the trend is rising, or an exponential decay model when the trend is falling. Fitted via linearized least squares.
Sightings
| Author | Source | Type | Date | Other |
|---|
Nomenclature
- Seen: The vulnerability was mentioned, discussed, or observed by the user.
- Confirmed: The vulnerability has been validated from an analyst's perspective.
- Published Proof of Concept: A public proof of concept is available for this vulnerability.
- Exploited: The vulnerability was observed as exploited by the user who reported the sighting.
- Patched: The vulnerability was observed as successfully patched by the user who reported the sighting.
- Not exploited: The vulnerability was not observed as exploited by the user who reported the sighting.
- Not confirmed: The user expressed doubt about the validity of the vulnerability.
- Not patched: The vulnerability was not observed as successfully patched by the user who reported the sighting.
Vulnerability timeline
Sightings and recorded dates, grouped by day · UTC
How durations are calculated
Following the VTEM framework (Black Hat USA 2015), time to patch starts when the vendor or a coordinator was informed, total time to patch at discovery, and disclosure to patch at public disclosure; vendor response time runs from the report to its acknowledgement. Time to exploit and time unpatched start at the earliest discovery or report, falling back to public disclosure. Unpatched time ends at the first recorded patch, or the calculation time when no patch is recorded. Exploitation to patch shows the interval between those two events; a published proof of concept is a public exploit, not exploitation.
Each result shows its source dates. A negative interval means the end event came first; when date-only inputs leave the order open, the result says so. Date-only inputs are approximate. The earliest evidence wins: KEV report dates and sightings are labelled as such. Records describing another vulnerability are listed but never calculated from, and a PoC alone does not establish exploitation. Missing patch evidence does not prove that no patch exists. Filters below change the event list only.
Loading timeline…
Loading…
Loading…
The MITRE ATT&CK techniques below are AI-generated suggestions, inferred from the description of the
vulnerability by the CIRCL/vulnerability-attack-technique-classification-roberta-base
model, served locally by ML-Gateway.
They have not been verified by an analyst and are provided for guidance only.
The approach is described in our paper Mapping CVEs to MITRE ATT&CK Techniques: A Curated Gold-Set Classifier and the Limits of LLM-Assisted Label Expansion.
Browse all ATT&CK techniques and the vulnerabilities related to each.
The approach is described in our paper Mapping CVEs to MITRE ATT&CK Techniques: A Curated Gold-Set Classifier and the Limits of LLM-Assisted Label Expansion.
Browse all ATT&CK techniques and the vulnerabilities related to each.
Loading…
Related by attack behaviour
Vulnerabilities whose description is nearest to this one in the vector space of the CIRCL/vulnerability-attack-technique-biencoder model. This is a similarity search over the bi-encoder space (plain cosine), not a classification, and it has no measured accuracy.